- Trials with a EudraCT protocol (147)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
147 result(s) found for: covid-19 sars-cov-2.
Displaying page 1 of 8.
EudraCT Number: 2021-000291-11 | Sponsor Protocol Number: IMRES | Start Date*: 2021-05-30 | |||||||||||
Sponsor Name:Medical University of Vienna | |||||||||||||
Full Title: Characterization of immune responsiveness after SARS-CoV-2 Vaccination in patients with Immunodeficiency or immunosuppressive therapy (COVID-19) | |||||||||||||
Medical condition: Vaccination against SARS-CoV-2 in immunocompromised patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001421-31 | Sponsor Protocol Number: QUINAVID-19 | Start Date*: 2020-04-06 | |||||||||||
Sponsor Name:Sociedad Española de Farmacia Hospitalaria | |||||||||||||
Full Title: Clinical trial randomized, unblinded and controled for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals. | |||||||||||||
Medical condition: SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000206-17 | Sponsor Protocol Number: COVID19_7 | Start Date*: 2021-03-10 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Studies of ongoing and completed SARS-CoV-2 infection (which causes COVID-19) within the healthcare in Stockholm County, with regard to vaccinations. | ||
Medical condition: Vaccination against COVID-19. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001565-37 | Sponsor Protocol Number: PrEP_COVID | Start Date*: 2020-04-03 |
Sponsor Name:ISGlobal | ||
Full Title: PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE FOR HIGH-RISK HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC (PrEP_COVID): A UNICENTRIC, DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL. | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004123-16 | Sponsor Protocol Number: 2019nCoV-302 | Start Date*: 2020-09-23 | |||||||||||
Sponsor Name:Novavax, Inc. | |||||||||||||
Full Title: A Phase 3, Randomised, Observer-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) with Matrix-M1™ ... | |||||||||||||
Medical condition: Prevention of COVID-19 caused by SARS-CoV-2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001054-57 | Sponsor Protocol Number: NL76562.100.21 | Start Date*: 2021-03-08 | |||||||||||
Sponsor Name:OLVG | |||||||||||||
Full Title: SARS-CoV-2 vaccination response in people living with HIV | |||||||||||||
Medical condition: COVID-19 vaccine response in people living with HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001227-41 | Sponsor Protocol Number: CSIC-FDA135-2021-01 | Start Date*: 2021-12-23 | |||||||||||
Sponsor Name:AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, M.P. (CSIC) | |||||||||||||
Full Title: A Randomized, Open-label, Standard-of-care comparative, Repositioning Clinical Trial to Evaluate the Efficacy and Safety of FDA-135 in combination with standard of care in the Treatment of Infectio... | |||||||||||||
Medical condition: SARS-CoV-2 virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001228-17 | Sponsor Protocol Number: CSIC-FDA277-2021-01 | Start Date*: 2022-02-11 | |||||||||||
Sponsor Name:AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, M.P. (CSIC) | |||||||||||||
Full Title: A Randomized, double-blind, Repositioning Clinical Trial, placebo controlled, to Evaluate the Efficacy and Safety of FDA-277 in combination with standard of care in the Treatment of Infection Cause... | |||||||||||||
Medical condition: SARS-CoV-2 virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001769-19 | Sponsor Protocol Number: CVG01 | Start Date*: 2021-04-15 | |||||||||||
Sponsor Name:GUVAX (Gothenburg University Vaccine Research Institute) | |||||||||||||
Full Title: Immune response to SARS-CoV-2 in health care workers, previously infected subjects, and immunocompromised subjects, before and after Covid-19 vaccination: a phase IV trial | |||||||||||||
Medical condition: SARS-COV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001362-35 | Sponsor Protocol Number: C4671034 | Start Date*: 2022-11-29 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE NIRMATRELVIR/RITONAVIR IN NONHOSPITALIZED PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH SYMPTOMATIC... | |||||||||||||
Medical condition: SARS-CoV-2 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) BG (Completed) HU (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002110-41 | Sponsor Protocol Number: CRUKD/20/002 | Start Date*: 2020-06-18 | |||||||||||
Sponsor Name:Cancer Research UK | |||||||||||||
Full Title: SPIKE-1 TRIAL: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated memb... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002449-41 | Sponsor Protocol Number: PRE-COVID | Start Date*: 2020-06-15 | |||||||||||
Sponsor Name:ANTONIO ANTELA LOPEZ | |||||||||||||
Full Title: Pilot trial on early treatment with hydroxychloroquine in patients with COVID-19 who do not have hospital admission at diagnosis. | |||||||||||||
Medical condition: Patients diagnosed with COVID-19, with positive PCR for SARS-CoV-2, without criteria for hospital admission. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001202-30 | Sponsor Protocol Number: NL73618.100.20 | Start Date*: 2021-05-04 |
Sponsor Name:Diakonessenhuis | ||
Full Title: SARS-CoV-2 immune response | ||
Medical condition: immune response to COVDI-19 vaccination | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002503-19 | Sponsor Protocol Number: 62586 | Start Date*: 2020-07-08 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: BCG vaccination to Reduce the impact of COVID-19 in healthcare workers (BRACE) Trial | |||||||||||||
Medical condition: SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000904-39 | Sponsor Protocol Number: MK-4482-013 | Start Date*: 2021-08-11 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-4482 for the Prevention of COVID-19 (Laboratory-confirmed SARS-CoV-2 Infection W... | |||||||||||||
Medical condition: Prophylaxis of COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) FR (Completed) HU (Completed) BG (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004889-35 | Sponsor Protocol Number: UCDCRC/21/10 | Start Date*: 2021-12-08 | ||||||||||||||||
Sponsor Name:University College Dublin | ||||||||||||||||||
Full Title: An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a booster mRNA vaccination dose against SARS-Co... | ||||||||||||||||||
Medical condition: Severe Acute Respiratory Syndrome Coronavirus 19 (COVID-19/SARS-CoV-2) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IE (Completed) NO (Completed) DE (Completed) ES (Ongoing) BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001960-28 | Sponsor Protocol Number: RCTVITD/SARS-CoV-19 | Start Date*: 2020-05-25 |
Sponsor Name:Investigation Institute Bioaraba | ||
Full Title: Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19) | ||
Medical condition: COVID-19 infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001409-21 | Sponsor Protocol Number: IMIB-DFC-2020-02 | Start Date*: 2020-04-01 |
Sponsor Name:FFIS | ||
Full Title: A prospective, multicenter, randomized, parallel, double-blind, placebo-controlled phase IIb clinical trial to evaluate intravenous infusion of Defibrotide in the prevention and treatment of respir... | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005423-37 | Sponsor Protocol Number: GHRMRIPH1001 | Start Date*: 2021-02-05 |
Sponsor Name:Raincy Montfermeil intercommunal hospital group | ||
Full Title: Impact évaluation of an ivermectin single dose administration in the early phase of COVID-19 to negative viral load in SARS-CoV-2 determined by RT-PCR_ IVERCoV. | ||
Medical condition: patients with COVID 19 symptoms for less than 72 hours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000623-13 | Sponsor Protocol Number: VIR-7831-5008 | Start Date*: 2021-07-29 | ||||||||||||||||
Sponsor Name:Vir Biotechnology, Inc. | ||||||||||||||||||
Full Title: A Phase 3 randomized, multi-center, open label study to assess the efficacy, safety, and tolerability of monoclonal antibody VIR-7831 (sotrovimab) given intramuscularly versus intravenously for the... | ||||||||||||||||||
Medical condition: Mild/moderate COVID-19 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) AT (Completed) IT (Ongoing) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
